Medicine Description shatoo 50/200 mg
shatoo 50/200 mg tablets is a medication that combines carbidopa and levodopa to manage symptoms of Parkinson's disease. Levodopa is converted into dopamine in the brain, a neurotransmitter that is deficient in patients with Parkinson's disease, helping to improve motor function and reduce symptoms such as tremors, rigidity, and bradykinesia. Carbidopa is included to inhibit the conversion of levodopa to dopamine outside the brain, allowing more levodopa to reach the central nervous system while minimizing peripheral side effects like nausea. This synergistic action enhances the therapeutic efficacy of levodopa, ensuring better control of Parkinson’s symptoms.
Indications and Uses of shatoo 50/200 mg tablets
- Management of Parkinson's disease
- Improvement of motor function in patients with Parkinson's
- Management of symptoms associated with Parkinson's disease, such as tremors and rigidity
Side Effects of shatoo 50/200 mg tablets
- Nausea
- Dizziness
- Headache
- Dry mouth
- Sleep disturbances
- Uncontrolled movements (dyskinesia)
- Hypotension
Storage and Handling
Store shatoo 50/200 mg tablets in a cool, dry place away from direct sunlight. Keep out of reach of children and do not store in damp or humid areas.
Patient Advice and Precautions
Patients should be monitored for changes in mood and behavior as well as for any signs of worsening symptoms. It is crucial to adhere to prescribed treatment regimens and consult a healthcare professional before making any changes. Alcohol consumption should be avoided, and patients should report any unusual side effects to their healthcare provider promptly.